Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
奧ppenheimer對Inari Medical發起覆蓋，給予超出市場表現評級，並宣佈目標價爲75美元。
Oppenheimer analyst Steve Lichtman initiates coverage on Inari Medical (NASDAQ:NARI) with a Outperform rating and announces Price Target of $75.
Oppenheimer 分析師Steve Lichtman 開始對Inari Medical (納斯達克:NARI)進行覆蓋，給予"跑贏大盤"評級，並宣佈目標價格爲75美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間